Medications for Ovarian Neoplasms

21 results

  • Carboplatin (carboplatin)

    (CARBOPLATIN)
    Cipla USA Inc.
    Usage: Carboplatin injection is indicated for the initial and secondary treatment of advanced ovarian carcinoma, used in combination with other chemotherapeutic agents. It is effective for patients with recurrent disease after prior chemotherapy, including those previously treated with cisplatin.

  • Carboplatin (carboplatin)

    (Carboplatin)
    Gland Pharma Limited
    Usage: Carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in combination with other chemotherapy agents, and for palliative treatment of recurrent ovarian carcinoma after prior chemotherapy, including in patients previously treated with cisplatin.

  • Carboplatin (carboplatin)

    (CARBOPLATIN)
    Eugia US LLC
    Usage: Carboplatin injection is indicated for the initial and palliative treatment of advanced ovarian carcinoma, used in combination with other approved chemotherapy agents. It is effective for patients who have recurrent ovarian carcinoma after prior treatment, including those previously treated with cisplatin.

  • Cisplatin (cisplatin)

    (Cisplatin)
    Accord Healthcare
    Usage: Cisplatin injection is indicated for the treatment of advanced testicular, ovarian, and bladder cancers.

  • Cisplatin (cisplatin)

    (Cisplatin)
    BluePoint Laboratories
    Usage: Cisplatin injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

  • Cisplatin (cisplatin)

    (Cisplatin)
    Teva Parenteral Medicines, Inc.
    Usage: Cisplatin Injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

  • Cisplatin (cisplatin)

    (CISplatin)
    Apotex Corp.
    Usage: Cisplatin Injection is indicated for use in combination therapy for metastatic testicular and ovarian tumors, post-surgery/radiotherapy. It is also used as a single agent for advanced transitional cell bladder cancer when local treatments are not viable.

  • Doxorubicin hydrochloride (doxorubicin hydrochloride)

    (Doxorubicin Hydrochloride)
    Dr. Reddy's Laboratories Inc.
    Usage: Doxorubicin hydrochloride liposome injection is indicated for treating recurrent or progressive ovarian cancer after platinum chemotherapy, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and in combination with bortezomib for multiple myeloma in patients with prior therapy but no previous bortezomib treatment.

  • Doxorubicin hydrochloride liposome (doxorubicin hydrochloride liposome)

    (Doxorubicin Hydrochloride Liposome)
    Baxter Healthcare Corporation
    Usage: Doxorubicin hydrochloride liposome injection is indicated for treating advanced ovarian cancer after platinum therapy failure, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and multiple myeloma in combination with bortezomib in patients having received prior therapy.

  • Gemcitabine (gemcitabine hydrochloride)

    (GEMCITABINE HYDROCHLORIDE)
    Meitheal Pharmaceuticals Inc.
    Usage: Gemcitabine for injection is indicated for advanced ovarian cancer (post-platinum therapy), metastatic breast cancer (after anthracycline failure), inoperable non-small cell lung cancer, and as first-line treatment for locally advanced or metastatic pancreatic adenocarcinoma.